Why the study?
The association between the MTHFR C677T (rs1801133) genetic polymorphism and MI in the presence of diabetes mellitus as a risk factor needed to be investigated.
Is the MTHFR C677T polymorphism associated with myocardial infarction in the presence of diabetes mellitus?
Is the MTHFR C677T polymorphism associated with myocardial infarction in the presence of diabetes mellitus?
The MTHFR C677T T/T homozygous genotype is significantly associated with myocardial infarction in patients with diabetes mellitus, highlighting a genetic risk factor interaction.
Answers are grounded in this paper and cite their sources.
MTHFR T/T may flag higher MI risk in DM; leaves open prospective validation before clinical adoption.
Myocardial infarction (MI) is a cardiovascular disease that occurs due to the blockage of the coronary artery. Subsequently, cardiac muscles receive a lower oxygen supply, which leads to the death of cardiac muscles. The etiology of MI is linked to various environmental, occupational, and genetic factors. Various studies have been conducted on the polymorphism of genes involved in MI. Previous studies have shown that different variants of the methylene tetrahydrofolate reductase (MTHFR) gene are involved in causing MI by altering the metabolism of folate and homocysteine. However, the genetic polymorphism of MTHFR C677T (rs1801133) and its association with MI in the presence of diabetes mellitus (DM) as a risk factor still needs to be investigated. This study recruited 300 participants who were divided into three groups, i.e., the control, MI, and MI-DM. The blood samples collected from the study participants were subjected to various biochemical tests and their clinical parameters were monitored. MTHFR C677T (rs1801133) genotyping was performed by Tetra ARMS PCR using predetermined primers. The MTHFR C677T (rs1801133) polymorphism was associated with MI in the presence of DM as a risk factor among the participants. The MTHFR C677T (rs1801133) T/T homozygous genotype was found to be significant among MI patients in the presence of DM as a risk factor.
No takes yet. Share an insight, caveat, or question.
Mallhi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: